Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.

Paolino, Giovanni; Di Nicola, Matteo Riccardo; Cantisani, Carmen; Mercuri, Santo Raffaele

Paolino, Giovanni; Di Nicola, Matteo Riccardo; Cantisani, Carmen; Mercuri, Santo Raffaele.

Paolino G; Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
Di Nicola MR; Dermatologic Clinic, Sapienza University of Rome, Rome, Italy.
Cantisani C; Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
Mercuri SR; Dermatologic Clinic, Sapienza University of Rome, Rome, Italy.

Dermatol Ther ; 34(4): e14972, 2021 07.

Article in English | MEDLINE | ID: covidwho-1228747

Subject(s)

COVID-19; Pityriasis Rosea; Telemedicine; Histamine Antagonists; Humans; Prodromal Symptoms; SARS-CoV-2; Steroids

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Pityriasis Rosea / COVID-19 Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2021 Document Type: Article Affiliation country: Dth.14972

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google